Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
7.59
-0.31 (-3.92%)
At close: Feb 21, 2025, 4:00 PM
7.85
+0.26 (3.43%)
After-hours: Feb 21, 2025, 6:05 PM EST
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $195.65 million as of February 21, 2025.
Market Cap
195.65M
Enterprise Value
-17.65M
1-Year Change
n/a
Ranking
Category
Stock Price
7.59
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has decreased from $402.09M to $195.65M, a decrease of -51.34%. That is a compound annual growth rate of -55.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 195.65M | -48.19% |
| Dec 31, 2024 | 377.64M | -6.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.92B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |